#United States #New York #Class Action #Securities Fraud #Hims & Hers

Hims & Hers Health Investors Have Opportunity to Lead Class Action Lawsuit

Background

In an urgent announcement, the Rosen Law Firm, a respected global investor rights law firm, has alerted purchasers of Hims & Hers Health, Inc. securities (NYSE: HIMS) about a significant opportunity to take part in a class action lawsuit. This lawsuit pertains to alleged securities fraud and invites investors who bought securities between August 4, 2025, and July 29, 2026, to join before the approaching November 2, 2026 deadline for lead plaintiffs.

What Investors Should Know

If you purchased Hims securities within this timeframe, you may be eligible for compensation without incurring any out-of-pocket fees. The class action lawsuit aims to recover losses for affected investors, offering a no-risk opportunity for individuals to be involved.

To participate, interested parties are encouraged to visit this link or contact attorney Phillip Kim via toll-free number 866-767-3653 or email at [email protected]. Completion of these steps is essential for those wishing to serve as lead plaintiffs, acting on behalf of other class members in the legal proceedings.

The Case Details

The lawsuit alleges that Hims & Hers Health, Inc. misled investors by making materially false statements and failing to disclose critical information regarding their operations. Key accusations include:
1. The company shared sensitive health information of consumers with third-party advertising platforms without proper disclosure.
2. Consumers were charged for prescription services almost immediately after submitting their medical intake forms, despite misleading indications that they would receive consultation from medical professionals to determine appropriate treatments.
3. Such actions have brought Hims & Hers Health under scrutiny from regulators, exposing the company to potential fees and penalties, undermining its previous statements regarding business stability and future prospects.

As the truth about these actions came to light, the value of Hims securities reportedly plummeted, causing significant financial losses for investors.

The Importance of Choosing the Right Legal Representation

The Rosen Law Firm emphasizes the importance of investors selecting qualified legal counsel with proven expertise in handling securities class actions. Many firms merely act as intermediaries and lack the necessary resources and experience to effectively represent clients in the complexities of such lawsuits. In stark contrast, the Rosen Law Firm has consistently achieved notable settlements on behalf of investors, including record outcomes in previous cases. Their experience is invaluable in navigating the securities litigation landscape, having recovered billions for clients and recognizing the urgency of fortifying legal representation at this juncture.

Next Steps for Investors

• - Visit: Use the link provided to access the Hims class action registration page.
• - Call: Speak with Phillip Kim for questions or clarifications regarding the lawsuit process.
• - Participate: Carefully consider the option to be a lead plaintiff or remain an absent member. It's vital to understand that individual recovery potential is not contingent on being a lead plaintiff, so each investor should weigh their options cautiously.

The Rosen Law Firm will provide updates and further information through their social media on platforms such as LinkedIn, Twitter, and Facebook.

Conclusion

This lawsuit presents a critical opportunity for investors of Hims & Hers Health, Inc. to take action regarding potential securities fraud. With a firm like the Rosen Law Firm advocating on behalf of investors, affected parties are positioned to seek justice effectively. Each investor should act promptly to ensure their rights are safeguarded and consider the implications of the court's forthcoming decisions in this matter.